BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 10439636)

  • 1. [Zafirlukast therapy of patients with mild-to-moderate bronchial asthma].
    Naményi M; Puha K; Pánczél G; Mikó P; Fäller K; Dér K
    Orv Hetil; 1999 Jun; 140(24):1353-6. PubMed ID: 10439636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of the leukotriene receptor antagonist zafirlukast for mild-to-moderate asthma. A randomized, double-blind, placebo-controlled trial.
    Suissa S; Dennis R; Ernst P; Sheehy O; Wood-Dauphinee S
    Ann Intern Med; 1997 Feb; 126(3):177-83. PubMed ID: 9027267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of asthmatic patients with zafirlukast].
    Naranjo RM; Olivares Elegia M; de la Coba RA
    Rev Alerg Mex; 2007; 54(1):3-6. PubMed ID: 17542248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of zafirlukast in the treatment of patients with bronchial asthma.
    Tsai JJ; Chan SC; Ho CK; Su YC; Feng TC
    J Microbiol Immunol Infect; 2001 Mar; 34(1):63-70. PubMed ID: 11321130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zafirlukast for symptomatic mild-to-moderate asthma: a 13-week multicenter study. The Zafirlukast Trialists Group.
    Fish JE; Kemp JP; Lockey RF; Glass M; Hanby LA; Bonuccelli CM
    Clin Ther; 1997; 19(4):675-90. PubMed ID: 9377612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of asthma with zafirlukast. Clinical experience and tolerability profile.
    Spector SL
    Drugs; 1996; 52 Suppl 6():36-46. PubMed ID: 8941502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zafirlukast in clinical practice: results of the Accolate Clinical Experience and Pharmacoepidemiology Trial (ACCEPT) in patients with asthma.
    Kemp JP; Korenblat PE; Scherger JE; Minkwitz M
    J Fam Pract; 1999 Jun; 48(6):425-32. PubMed ID: 10386485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of Zafirlukast ('Accolate') in the management of patients with mild-to-moderate asthma.
    Chukwu C; Okpapi J; Ige MO; Obodo JO
    West Afr J Med; 2000; 19(2):111-9. PubMed ID: 11070746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced prostaglandin E2 secretion in sputum from asthmatic patients after zafirlukast therapy.
    Tsai JJ; Su YC; Chan SC; Ho CK; Feng TC
    J Formos Med Assoc; 2001 Apr; 100(4):241-3. PubMed ID: 11393122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of leukotriene receptor antagonist therapy on the risk of asthma exacerbations in patients with mild to moderate asthma: an integrated analysis of zafirlukast trials.
    Barnes NC; Miller CJ
    Thorax; 2000 Jun; 55(6):478-83. PubMed ID: 10817796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zafirlukast: the first leukotriene-receptor antagonist approved for the treatment of asthma.
    Kelloway JS
    Ann Pharmacother; 1997 Sep; 31(9):1012-21. PubMed ID: 9296243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Influence of zafirlukast on pulmonary functions and quality of life in patients with asthma].
    Xiang XD; Zhou R; Chen Y
    Hunan Yi Ke Da Xue Xue Bao; 2001 Jun; 26(3):251-3. PubMed ID: 12536697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asthma outcome changes associated with use of the leukotriene-receptor antagonist zafirlukast.
    Klingman D; Bielory L; Wang Y; Silverman S; Bell CF; Joy KA; Dever MT; Jones DA
    Manag Care Interface; 2001 Feb; 14(2):62-6. PubMed ID: 11228819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Summary of clinical trials with zafirlukast.
    Calhoun WJ
    Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 2):S238-45; discussion S245-8. PubMed ID: 9647606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of zafirlukast on bronchial asthma and allergic rhinitis.
    Piatti G; Ceriotti L; Cavallaro G; Ambrosetti U; Mantovani M; Pistone A; Centanni S
    Pharmacol Res; 2003 Jun; 47(6):541-7. PubMed ID: 12742009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zafirlukast treatment for acute asthma: evaluation in a randomized, double-blind, multicenter trial.
    Silverman RA; Nowak RM; Korenblat PE; Skobeloff E; Chen Y; Bonuccelli CM; Miller CJ; Simonson SG
    Chest; 2004 Nov; 126(5):1480-9. PubMed ID: 15539716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term safety and efficacy of zafirlukast in the treatment of asthma: interim results of an open-label extension trial.
    Grossman J; Smith LJ; Wilson AM; Thyrum PT
    Ann Allergy Asthma Immunol; 1999 Apr; 82(4):361-9. PubMed ID: 10227334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An open study to evaluate the safety and efficacy of zafirlukast ("Accolate") in patients with mild to moderate asthma in Ibadan, Nigeria.
    Ige OM; Onadeko BO
    West Afr J Med; 2001; 20(4):220-6. PubMed ID: 11885876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zafirlukast: a new treatment for asthma.
    Kupecz D
    Nurse Pract; 1997 May; 22(5):182, 185-6, 189-90. PubMed ID: 9172242
    [No Abstract]   [Full Text] [Related]  

  • 20. [New drugs in asthma treatment. Leukotriene receptor blockers and leukotriene synthesis inhibitors].
    Männistö J; Haahtela T
    Nord Med; 1997 Apr; 112(4):122-5. PubMed ID: 9198809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.